- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Eribulin mesylate erlotinib
Total 3066 results
-
Monika Joshi, MDPfizer; Eisai Inc.; Big Ten Cancer Research ConsortiumTerminatedMetastatic Urothelial Cell CancerUnited States
-
Consorzio OncotechActive, not recruitingMetastatic Breast CancerItaly
-
Eisai Inc.Merck Sharp & Dohme LLCCompleted
-
Eisai LimitedCompletedMetastatic Breast CancerUnited Kingdom, Bulgaria, Russian Federation
-
Eisai Inc.CompletedMetastatic Breast CancerPoland, Ukraine, United States, Taiwan, Spain, Argentina, Bulgaria, Romania, South Africa, Australia, Canada, Singapore, Russian Federation, Brazil, Germany, Hungary, Italy, Israel, Greece, Mexico, Belgium, Czechia, France
-
Michael PradosNational Cancer Institute (NCI); Genentech, Inc.TerminatedAdult Brain TumorsUnited States
-
NCIC Clinical Trials GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerCanada
-
Yonsei UniversityUnknown
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Urothelial Carcinoma | Recurrent Urothelial Carcinoma | Unresectable Urothelial Carcinoma | Advanced Urothelial CarcinomaUnited States
-
Seoul National University HospitalCompletedAcute Postthoracotomy Pain | Chronic Postthoracotomy Pain | Hypotension After Bolus DoseKorea, Republic of
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.CompletedClear Cell Renal Cell Carcinoma
-
Australia New Zealand Gynaecological Oncology GroupMerck Sharp & Dohme LLC; Eisai Inc.RecruitingUterine Carcinosarcoma | Ovarian CarcinosarcomaCanada, Australia, United Kingdom
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompleted
-
Eisai Inc.CompletedBreast Cancer | Estrogen Receptor Positive TumorUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
Baylor College of MedicineRecruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission | Chronic Myeloid Leukemia in RemissionUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast CarcinomaUnited States
-
University Hospital, LilleNovartisCompletedGraft Versus Host DiseaseFrance, Belgium
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast CancerBelgium, Canada, France, Italy, Spain, United Kingdom, Hungary, Poland, United States, Korea, Republic of, Brazil, India, Japan, Russian Federation, China, Taiwan, Netherlands, Germany, South Africa, Argentina
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
Eisai GmbHCompletedLocally Advanced or Metastatic Breast CancerGermany
-
Fujian Cancer HospitalUnknown
-
Fred Hutchinson Cancer CenterCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Massachusetts General HospitalEisai Inc.Active, not recruitingAngiosarcoma | Epithelioid HemangioendotheliomaUnited States
-
Institut Cancerologie de l'OuestCompleted
-
Fudan UniversityNot yet recruiting
-
Eisai Inc.Completed
-
Eisai Co., Ltd.CompletedBreast Cancer | Breast Tumors | Triple Negative Breast Cancer | Cancer of Breast | HER2-Negative Breast CancerChina
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Fox Chase Cancer CenterNovartisTerminated
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Shengjing HospitalNot yet recruitingTriple Negative Breast CancerChina
-
Henan Cancer HospitalRecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Peking University Third HospitalUnknownNonsmall Cell Lung CancerChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Novartis PharmaceuticalsTerminatedMyelogenous LeukemiaUnited States, Germany, Belgium, Italy, Spain, Korea, Republic of, Brazil, Japan, Australia, Czech Republic
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Translational Research Center for Medical Innovation...Kyoto Breast Cancer Research NetworkCompleted
-
M.D. Anderson Cancer CenterActive, not recruitingBreast Inflammatory Carcinoma | Recurrent Breast Inflammatory Carcinoma | Stage IV Breast Inflammatory CarcinomaUnited States
-
Guangdong Association of Clinical TrialsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Seoul St. Mary's HospitalNovartisUnknownChronic Myeloid LeukemiaKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Italian Sarcoma GroupEisai Inc.Recruiting
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingCML, Chronic Phase; TKIChina
-
University of Colorado, DenverGenentech, Inc.CompletedRenal Cell CarcinomaUnited States